Kalytera Announces Settlement of Debt Transactions Approval of Shares for Services and Settlement of Debt Transaction with The Salzman Group of Israel
Kalytera Therapeutics, Inc. (KALY.V) (KALTF) (the “Company” or “Kalytera”) today announced that it has entered into an agreement to pay amounts owing to a service provider for past services in common shares of the Company (“Common Shares”). The transaction is subject to approval by the TSX Venture Exchange (“TSXV”). https://kalytera.co/investors/news-archive/?2018
Comments